AACE 2017
Once-weekly levothyroxine vs. daily levothyroxine proved safe and effective for the treatment of hypothyroidism in non-adherent young and middle-aged adults.
AACE 2017
Synthroid was associated with an 11% lower likelihood of having TSH labs out of range when compared with similar patients taking generic levothyroxine.
News
Significantly lower total T4 absorption was noted.
News
The manufacturing discontinuation was a business decision made by the Company.
Safety Alerts and Recalls, Uncategorized
Westminster Pharmaceuticals announced a recall of all lots of Levothyroxine and Liothyronine (Thyroid Tablets) 15mg, 30mg, 60mg, 90mg, 120mg as the product was manufactured using active pharmaceutical ingredients (API) from a company that was found to have deviated from the Food and Drug Administration (FDA)’s Good Manufacturing Practices. FDA laboratory tests confirmed Sichuan Friendly Pharmaceutical’s…
News
The American Thyroid Association (ATA) has released new evidence-based recommendations to guide clinicians in diagnosing and managing thyroid disease during pregnancy and the postpartum period.
News
The Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xenical (orlistat; Genentech) capsules regarding the risk of loss of virological control in patients with HIV infection taking concomitant antiretroviral agents.
News
Researchers report an increase in overall prescription drug use among adults in the United States between 1999-2012. Findings from the study are published in JAMA.
News
The Endocrine Society has issued a response to the USPSTF's final recommendation statement on screening for thyroid dysfunction.
